Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,072 | 865 | 98.6% |
| Consulting Fee | $150.00 | 1 | 1.1% |
| Education | $30.63 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,459 | 109 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,241 | 65 | $0 (2024) |
| PFIZER INC. | $1,196 | 100 | $0 (2024) |
| ABBVIE INC. | $966.18 | 54 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $767.80 | 50 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $622.01 | 38 | $0 (2024) |
| GlaxoSmithKline, LLC. | $504.24 | 38 | $0 (2024) |
| Amgen Inc. | $462.48 | 31 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $453.90 | 31 | $0 (2024) |
| Allergan, Inc. | $413.39 | 41 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,708 | 91 | PFIZER INC. ($271.26) |
| 2023 | $1,533 | 90 | AbbVie Inc. ($291.84) |
| 2022 | $1,451 | 92 | Novo Nordisk Inc ($238.62) |
| 2021 | $1,037 | 56 | AbbVie Inc. ($178.58) |
| 2020 | $379.90 | 25 | PFIZER INC. ($65.99) |
| 2019 | $2,150 | 149 | AstraZeneca Pharmaceuticals LP ($284.47) |
| 2018 | $2,691 | 183 | AstraZeneca Pharmaceuticals LP ($367.53) |
| 2017 | $2,302 | 184 | PFIZER INC. ($271.30) |
All Payment Transactions
870 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: PAIN | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: VACCINES | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: PAIN | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: PAIN | ||||||
| 10/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Cardio-renal | ||||||
| 10/28/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Endocrinology | ||||||
| 10/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $10.09 | General |
| Category: Bone Health | ||||||
| 10/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Obesity | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Gastroenterology | ||||||
| 10/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: NEUROLOGY | ||||||
| 09/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Inflammation | ||||||
| 09/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.18 | General |
| 09/12/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: VACCINES | ||||||
| 08/28/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: PSYCHIATRY | ||||||
| 08/27/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 343 | 397 | $62,785 | $23,129 |
| 2022 | 8 | 371 | 434 | $75,244 | $28,582 |
| 2021 | 8 | 355 | 428 | $66,745 | $24,675 |
| 2020 | 9 | 307 | 387 | $64,858 | $22,765 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 75 | 75 | $23,400 | $9,082 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 79 | $15,563 | $5,422 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 103 | $13,699 | $5,070 | 37.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 20 | 20 | $3,660 | $1,440 | 39.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 83 | 83 | $3,984 | $1,401 | 35.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $1,407 | $597.24 | 42.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 16 | $1,072 | $115.72 | 10.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 80 | 80 | $24,960 | $9,898 | 39.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 103 | $20,291 | $7,715 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 111 | $14,763 | $5,304 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $4,848 | $1,739 | 35.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 76 | 76 | $3,648 | $1,305 | 35.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 18 | 18 | $3,294 | $1,265 | 38.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,167 | $840.85 | 38.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 19 | $1,273 | $515.85 | 40.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 77 | 77 | $24,024 | $9,691 | 40.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 69 | 100 | $19,700 | $7,314 | 37.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 99 | $13,167 | $5,047 | 38.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 73 | 73 | $3,504 | $1,279 | 36.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $3,333 | $805.03 | 24.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 18 | 18 | $1,206 | $283.50 | 23.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 15 | 23 | $1,541 | $203.65 | 13.2% |
| 81003 | Automated urinalysis test | Office | 2021 | 20 | 27 | $270.00 | $52.36 | 19.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 74 | 119 | $23,443 | $7,214 | 30.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 56 | 56 | $17,472 | $6,226 | 35.6% |
About Dr. Adam Childs, M.D
Dr. Adam Childs, M.D is a Family Medicine healthcare provider based in Murfreesboro, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1992978845.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Childs, M.D has received a total of $13,253 in payments from pharmaceutical and medical device companies, with $1,708 received in 2024. These payments were reported across 870 transactions from 74 companies. The most common payment nature is "Food and Beverage" ($13,072).
As a Medicare-enrolled provider, Childs has provided services to 1,376 Medicare beneficiaries, totaling 1,646 services with total Medicare billing of $99,151. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Murfreesboro, TN
- Active Since 04/10/2008
- Last Updated 01/14/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1992978845
Products in Payments
- FARXIGA (Drug) $844.08
- JARDIANCE (Drug) $657.18
- UBRELVY (Drug) $439.89
- XARELTO (Drug) $409.67
- NURTEC ODT (Drug) $380.45
- CHANTIX (Drug) $360.52
- VRAYLAR (Drug) $339.97
- REXULTI (Drug) $316.46
- Saxenda (Drug) $303.80
- TRELEGY ELLIPTA (Drug) $298.23
- XIFAXAN (Drug) $276.76
- QULIPTA (Drug) $270.94
- JANUVIA (Drug) $262.71
- Ozempic (Drug) $251.70
- Trintellix (Drug) $248.23
- Otezla (Drug) $193.51
- GARDASIL (Biological) $191.16
- MYDAYIS (Drug) $190.96
- ZENPEP (Drug) $184.24
- Victoza (Drug) $183.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Murfreesboro
Dr. Scott Eller, M.d, M.D
Family Medicine — Payments: $18,623
Dr. Thomas Helton, Md, MD
Family Medicine — Payments: $15,111
Dr. Laura Born, Md, MD
Family Medicine — Payments: $13,627
Dennis Carter, Md, MD
Family Medicine — Payments: $11,679
Nicholas Cote, D.o, D.O
Family Medicine — Payments: $10,359
Akashia Anderson, M.d, M.D
Family Medicine — Payments: $10,110